ResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare Conference
ResMed (NYSE: RMD) CEO Mick Farrell is set to participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on June 14, 2022, at approximately 1:20 p.m. PDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ResMed (NYSE: RMD) CEO Mick Farrell is set to participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on June 14, 2022, at approximately 1:20 p.m. PDT. This event will take place at the Terranea Resort in Rancho Palos Verdes, California. Interested parties can access a live webcast and a replay of the event via ResMed’s investor relations website, available for 12 hours post-event until June 14, 2023. ResMed focuses on innovative solutions for chronic disease management and aims to improve quality of life while reducing healthcare costs globally.
Positive
- Participation in a prominent healthcare conference may raise investor interest.
- Highlighting innovative solutions aligns with market trends towards healthcare technology.
Negative
- None.
Details
News Market Reaction – RMD
The recorded move for RMD in the trading session of this news was +1.73%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Tuesday, June 14, 2022, beginning at approximately 1:20 p.m. (Pacific Daylight Time) at the Terranea Resort in Rancho Palos Verdes, California.
More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately 12 hours after the live webcast ends and will be accessible through June 14, 2023.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| Amy Wakeham | Jayme Rubenstein |
| +1 858.836.5000 | +1 858.836.6798 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.